Skip to main content
. 2019 Jan 1;10(3):602–610. doi: 10.7150/jca.28842

Table 4.

Death risks of surgery strategies over NS among patients receiving chemotherapy for the sensitivity analyses

Surgery strategies All cohort Propensity score matching cohort Coarsened exact matching method weighted cohort
HR a (95% CI) P value HR b (95% CI) P value HR c (95% CI) P value
NS Reference Reference Reference
GO 0.61 (0.55, 0.67) <0.001 0.56 (0.46, 0.69) <0.001 0.64 (0.58, 0.70) <0.001
MO 0.92 (0.82, 1.03) 0.154 0.94 (0.77, 1.15) 0.524 1.02 (0.95, 1.11) 0.557
SPM 0.59 (0.51, 0.69) <0.001 0.60 (0.49, 0.73) <0.001 0.63 (0.57, 0.69) <0.001

a After adjustment for age, race, SEER region, year of diagnosis, marriage status, primary tumor location and histology whose P value <0.05 in the univariable Cox regression analysis.

b After adjustment for year of diagnosis, primary tumor location and histology whose P value <0.05 in the univariable Cox regression analysis.

c After adjustment for age, sex, race, SEER region, year of diagnosis, marriage status, primary tumor location and histology whose P value <0.05 in the univariable Cox regression analysis.

Abbreviations: HR, hazard ratio; CI, confidence interval; NS, no surgery; GO, gastrectomy only; MO, metastasectomy only; SPM, surgery to both primary and metastatic tumor.